• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Events

Free public event on the sidelines of ECTMIH 2019

16 September 2019

Liverpool, UK

Better than boiling oil or amputation? Stories behind the treatment needs of two of the world’s most neglected tropical diseases, cutaneous leishmaniasis and mycetoma

Monday, 16 September 2019, 14:00-15:30
Foresight Centre, Liverpool, UK

What links someone bitten by a sandfly while paddling down the Essequibo River in Guyana to a shepherd in Sudan who steps on a thorn with bare feet? The answer is…infection by some of the most neglected among the neglected tropical diseases listed by the World Health Organization. Cutaneous leishmaniasis (more easily known as CL) and mycetoma both lack effective treatment options that are short and non-toxic. There are some 600,000 to 1.2 million new cases of CL every year, while the global burden of mycetoma is unknown, as it has been so little studied.

Join us at Liverpool’s Foresight Centre, on the sidelines of the 2019 European Congress for Tropical Medicine and International Health, for the engaging stories of Pip Stewart, a British adventurer who contracted CL on a record-breaking paddling trip in the Amazon, and two researchers working on the first-ever clinical trial for a fungal mycetoma treatment, Dr Borna Nyaoke-Anoke, a physician and clinical researcher from the Drugs for Neglected Diseases initiative (DNDi) based in Nairobi, Kenya, and Dr Sahar Bakhiet, a microbiologist at the Mycetoma Research Centre in Khartoum, Sudan who works with communities affected by mycetoma.

Speakers

Pip Stewart profile photo

Pip Stewart

Pip Stewart is a journalist, poet, and presenter. She has cycled halfway around the world (16,000km from Malaysia to London), and has a degree in Modern History and Politics from Oxford University, and a masters in Journalism from the University of Hong Kong. In 2018 Pip found herself in a relationship with a flesh-eating parasite, leishmaniasis, after a world-first, 2.5 month, paddling expedition through dense Amazon jungle. Whilst she’s a big advocate of connection she wouldn’t, however, recommend getting involved with a flesh-eating parasite if it can be avoided.

Borna Nyaoke Anoke profile photo

Dr Borna Nyaoke-Anoke

Dr Borna Nyaoke-Anoke is a Kenyan physician and clinical researcher who manages clinical trials for the Drugs for Neglected Diseases initiative and the Global Antibiotic Research and Development Partnership in Nairobi. Liverpool is no stranger to her, as she earned her Master of Public Health from the University of Liverpool. Dr Nyaoke-Anoke was named one of the Top 40 Women Under 40 in Kenya in 2017.

Sahar Bakhiet profile photo

Dr Sahar Bakhiet

Dr Sahar Bakhiet is the Head of the Department of Molecular Microbiology at the Institute of Endemic Diseases and Head of Research at the Mycetoma Research Centre in Khartoum, Sudan. She was moved to change her research focus from visceral leishmaniasis to mycetoma after seeing small children with amputated limbs as a result of the fungal disease.

Practical information

Date: Monday, 16 September 2019
Time: 14:00-15:30
Venue: Foresight Centre 1 Brownlow St Liverpool L69 3GL UK

This event is free, no registration is needed.

Other events

Loading...
16 July 2025, 1 PM Khartoum

Online webinar

Mycetoma: a neglected disease affecting thousands of people

25 June 2025, 12:30 PM Brazil

Online webinar

NTDs around the world – Colombia

18 June 2025

Online

Antiviral Drug Discovery (AViDD) Open Science Forum

16-18 June 2025

São Paulo, Brazil

SciBiz Conference 2025

See all

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License